乙型肝炎肝硬化患者发生门脉高压性胃病出血相关因素分析

doi:10.3969/j.issn.1672-5069.2017.04.013

摘要/Abstract

摘要： 目的分析乙型肝炎肝硬化患者发生门脉高压性胃病出血的相关因素。方法 2014年1月~2015年12月纳入128例乙型肝炎肝硬化患者,对其临床资料进行回顾性分析。根据因素的不同分类,进行单因素分析,对有统计学意义的因素赋值,再行Logistic多因素回归分析,以获得影响乙型肝炎肝硬化患者发生门脉高压性胃病出血的独立危险因素。结果在符合纳入条件的128例乙型肝炎肝硬化患者中,49例（38.3%）发生门脉高压性胃病出血,其中粘膜炎症性糜烂出血41例（32.0%）,溃疡性出血8例（6.3%）;胃部有基础疾病的患者发生门脉高压性胃病出血的比例为60.0%,显著高于胃部没有基础疾病的患者（30.1%,P<0.05）,有幽门螺旋杆菌（HP）感染的患者发生门脉高压性胃病出血的比例为54.8%,显著高于无HP感染的患者（33.0%,P<0.05）,存在腹水的患者发生门脉高压性胃病出血的比例为46.3%,显著高于无腹水的患者（23.9%,P<0.05）,Child-Pugh C级、B级和A级患者发生门脉高压性胃病出血的比例分别为58.3%、41.5%和15.4%（P<0.05）,重度、中度和轻度食管静脉曲张（EV）患者发生门脉高压性胃病出血的比例分别为51.8%、41.9%和6.9%（P<0.05）,抗病毒治疗不规律的患者发生门脉高压性胃病出血的比例为55.6%,显著高于抗病毒治疗规律的患者（31.5%,P<0.05）,门静脉内径>14 mm的患者发生门脉高压性胃病出血的比例为48.3%,显著高于门静脉内径≤14 mm的患者（30.0%,P<0.05）,脾静脉内径>9 mm的患者发生门脉高压性胃病出血的比例为48.4%,显著高于脾静脉内径≤9 mm的（28.8%,P<0.05）;多因素分析显示胃部存在基础疾病、Child-Pugh 分级差、EV程度高和门静脉内径宽为发生门脉高压性胃病出血的独立危险因素。结论应针对存在出血风险的乙型肝炎肝硬化患者给予风险控制,早期防治。

关键词: 肝硬化, 门脉高压性胃病, 上消化道出血, 相关因素

Abstract: Objective To analyze the risk factors for gastric bleeding in patients with hepatitis B-induced liver cirrhosis and portal hypertensive gastropathy （PHG）. Methods 128 hepatitis B liver cirrhosis patients with PHG were retrospectively analyzed between January 2014 and December 2015. The incidence of gastric bleeding in each condition was compared. The multivariate Logistic regression analysis was performed to get independent risk factors when any significant statistical results were found. Results In 128 eligible patients with hepatitis B cirrhosis and PHG,49 patients（38.3%） had acute gastric bleeding;the prevalence of acute gastric bleeding in patients with and without underlying gastric diseases were 60.0% vs. 30.1%（P<0.05）,with and without Helicobacter pylori infection were 54.8% vs. 33.0% （P<0.05）,with and without ascites were 46.3% vs. 23.9% （P<0.05）,with Child-Pugh class C,class B and class A were 58.3%,41.5% and 15.4%（P<0.05）,with severe, moderate and mild esophageal varices（EV） were 51.8%,41.9% and 6.9%（P<0.05）,with and without regular antiviral therapy were 55.6% vs. 31.5% （P<0.05）,with portal vein diameter wider than and less than 14 mm were 48.3% vs. 30.0% （P<0.05）,with splenic vein diameter wider than and less than 9 mm were 48.4% vs. 28.8% （P<0.05）;Multivariate analysis showed that underlying gastric diseases,poor Child-Pugh classification, severe EV degree and wider portal vein diameter were the independent risk factors for acute gastric bleeding in patients with hepatitis B cirrhosis and PHG. Conclusion The patients with hepatitis B cirrhosis and PHG have a risk of gastrointestinal bleeding,and should be supervised for early prophylaxis and treatment.

Key words: Liver cirrhosis, Portal hypertensive gastropathy, Gastrointestinal bleeding, Risk factors

谌渐辉, 马林. 乙型肝炎肝硬化患者发生门脉高压性胃病出血相关因素分析[J]. 实用肝脏病杂志, 2017, 20(4): 431-434.

Chen Jianhui, Ma Lin.. Risk factors for gastric bleeding in patients with hepatitis B-induced liver cirrhosis and portal hypertensive gastropathy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 431-434.

参考文献

[1] Garg H,Gupta S,Anand AC,et al. Portal hypertensive gastropathy and gastric vascular ectasia. Indian J Gastroenterol,2015,4（5）:163-171.
[2] Smith LA,Morris AJ,Stanley AJ. The use of hemospray in portal hypertensive bleeding：a case series. J Hepatol,2014,60（2）:457-460.
[3] 霍宏蕾,董培玲,范丽娟,等. 肝硬化门脉高压性胃病临床分析. 北京医学,2012,34（3）:219-220.
[4] 张文辉,孙李建,韩军,等. 肝硬化门静脉高压性胃病935例临床分析. 中华保健医学杂志,2012,14（6）:449-451.
[5] 王庆亮,李晓杰,胡昆鹏,等. 无创性预测乙型肝炎肝硬化门脉高压性胃病的Logistic回归模型. 中华医学杂志,2015,95（18）:152-154.
[6] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2015年版）. 实用肝脏病杂志,2016,19（3）：Ⅴ-ⅩⅩⅢ.
[7] 中国中西医结合学会消化系统疾病专业委员会. 肝硬化中西医结合诊治方案. 现代消化及介入诊疗,2005,10（2）:119-121.
[8] McCormark TT,Sims J,Eyr Brook I,et a1. Gastric lesions in portal hypertension:inflammatory gastritis or congestive gastropathy. Gut,1985,26（11）:1226-1232.
[9] 中华医学会消化病学分会,中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治共识.中华肝脏病杂志,2008,16（8）:564-570.
[10] Biecker E. Portal hypertension and gastrointestinal bleeding:Diagnosis,prevention and management. World J Gastroenterol,2013,19（31）:5035-5050.
[11] Hejda V. Late complications of liver cirrhosis-management of gastrointestinal bleeding in the presence of portal hypertension. Vnitr Lek,2016,62（Suppl2）:318-320.
[12] 林尤冠,孙龙. 门脉高压性胃病相关危险因素分析. 海南医学,2013,24（3）:343-344.
[13] Garcia-Tsao G,Abraldes J,Berzigotti A,et al. Portal hypertensive bleeding in cirrhosis:risk stratification,diagnosis and management-2016 practice guidance by the American association for the study of liver diseases. Hepatology,2016,10（9）:94-96.
[14] Aoyama T,Oka S,Aikata H,et al. Major predictors of portal hypertensive enteropathy in patients with liver cirrhosis. J Gastroenterol Hepatol,2015,30（1）:124-130.
[15] 高长泰,杨含腾,郭应兴,等. 门脉高压症出血组与未出血组门静脉压力的对照研究. 实用放射学杂志,2015,6（2）:105-107.
[16] Montasser MF,Abdella HM,Samy AH. Evaluation of venous ammonia level,splenic longitudinal diameter,portal vein and splenic vein diameters as non-invasive indicators for the presence of portosystemic collaterals in egyptian cirrhotic patients. J Gastroenterol,2014,4（6）:265-274.
[17] Ferraz AA,Campos JM,Jr D AJ,et al. Influence of the inversion of the portal/splenic vein diameter in the results of the surgical treatment of schistossomotic portal hypertension. Rev Col Bras Cir,2011,38（38）:35-40.
[18] 赵超占,曾辉,吴建军,等. 超声检查诊断肝硬化门静脉高压症临床价值研究. 实用肝脏病杂志,2016,19（4）:455-458.
[19] 石艳,肖绍树. 肝炎肝硬化门脉高压合并食管胃静脉曲张破裂出血与再出血危险性的预测. 中华实验和临床感染病杂志电子版,2012,6（4）:83-84.
[20] 贲立军,李志勇. 肝硬化门脉高压性胃病278例临床分析. 现代中西医结合杂志,2011,20（2）:197-198.
[21] 房媛,李用国. 抗病毒治疗对乙型肝炎肝硬化门静脉高压症的影响. 医学综述,2015,21（24）:4507-4509.
[22] Sakamoto Y,Oho K,Toyonaga A,et al. Effect of helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension. J Gastroenterol Hepatol,2013,28（9）:1444-1449.